CriticalPoint Hires Erin Spaulding as Managing Director to Expand the Firm with Valuation Capabilities

We are pleased to announce that Erin Spaulding has joined CriticalPoint where she will be focused on building and leading the firm’s Valuation practice. She will be advising clients on a range of valuation issues, including transaction advisory (fairness opinions, purchase price allocations, shareholder exits, stock-based compensation), tax compliance (transfer pricing, gift & estate planning, […]

CriticalPoint Advises Addtronics, a Portfolio Company of Kaho Partners, on their Acquisition of Colanar

August 7th, 2024 – CriticalPoint is pleased to announce that it served as the exclusive financial advisor to Addtronics LLC. (“Addtronics”), a portfolio company of Kaho Partners, on its acquisition of Colanar, Inc. (“Colanar”). Located in Deep River, CT, Colanar (www.colanar.com) offers a range of specialty products and solutions, including full lines, benchtop systems, specialty […]

CriticalPoint Advises Lux Speed Inc. in connection with its Sale to Smartaira, a portfolio company of SDC Capital Partners 

July 11th, 2024 – CriticalPoint is pleased to announce that it served as exclusive financial advisor to Lux Speed Inc (“Lux Speed”) in connection with its sale to Smartaira, a portfolio company of SDC Capital Partners (“SDC”). Florida-based multifamily internet service provider Lux Speed has been acquired by Smartaira, a leader in fiber-based, community-wide internet […]

CriticalPoint Advises Luxium Solutions, a portfolio company of SK Capital Partners and Edgewater Capital Partners, in its acquisition of Inrad Optics 

CriticalPoint Advises Luxium Solutions, a portfolio company of SK Capital Partners and Edgewater Capital Partners, on its acquisition of Inrad Optics

July 10th, 2024 – CriticalPoint is pleased to announce that it advised Luxium Solutions, LLC (“Luxium”), a worldwide technology leader and provider of high-performance crystals used in photonics and radiation detection applications, in its acquisition of Inrad Optics, Inc. (“Inrad Optics”), a provider of advanced optical components, assemblies and systems. This strategic acquisition strengthens Luxium’s […]

Transitioning From Ownership – Your Exit Plan to Maximize Value

Transitioning Business Ownership article

When the time comes that transitioning away from business ownership becomes a relevant and realistic alternative, whether now or in a few years’ time, taking appropriate actions can help secure a higher value for your business. As we emerge from the tumultuous M&A environment experienced over the past few years, we are hearing more and […]

CriticalPoint Advises Info Solutions on its Sale to Custom Computer Solutions, a Portfolio Company of Columbia River Partners 

SERVER ROOM WITH INFO SOLUTIONS LOGO

May 31, 2024 – CriticalPoint is pleased to announce that it represented Info Solutions, LLC (“Info Solutions” or the “Company”), a growing technology infrastructure consulting, integration and management firm, on its sale to Custom Computer Specialists, (“CCS”), a portfolio company of Columbia River Partners. Headquartered in Wilmington, Delaware, Info Solutions is a rapidly growing provider […]

CriticalPoint Advises PLX, Inc. on its Sale to Luxium Solutions, a portfolio company of SK Capital Partners and Edgewater Capital Partners

CriticalPoint is pleased to announce CriticalPoint is pleased to announce that it represented PLX, Inc. and PLX UK, Ltd. (collectively, “PLX” or the “Company”), a leading designer and manufacturer of high-precision optical assemblies and products, on its sale to Luxium Solutions, LLC (“Luxium”), a portfolio company of SK Capital Partners, LP (“SK Capital”) and Edgewater Capital Partners, LP (“Edgewater”).

CriticalPoint Advises Alcanza Clinical Research, a Portfolio Company of Martis Capital, on their Acquisition of Innovation Medical Research Center

April 9, 2024– CriticalPoint is pleased to announce that it served as the exclusive financial advisor to Alcanza Clinical Research, a portfolio company of Martis Capital, on its acquisition of Innovation Medical Research Center (“Innovation”). Located in Palmetto Bay, Fla., Innovation conducts Phase I to Phase IV clinical trials in key therapeutic areas such as […]